Method for efficiently expressing structural proteins of Senecavirus A
A structural protein and protein technology, applied in the field of genetic engineering, can solve problems such as uneven expression of structural proteins, and achieve the effects of avoiding molecular sieve chromatography purification, increasing yield, and improving expression efficiency.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0091] Example 1 Soluble expression of a type A seneca virus protein
[0092] 1. Construction of the expression vector of the Sena virus protein recombinant expression vector
[0093] (1) Designing a gene sequence THS of the encoded fusion tag protein consisting of the originally described above, where T is the nucleotide sequence of the translation start zone, and H is a nucleotide sequence encoding a group-containing label, and S is encoded Nucleotide sequences of saproprine yeast small ubiquitin-like modes (SUMO); nucleotide sequences of THS, such as SEQ ID NO.11.
[0094] (2) The above THS gene sequence is respectively connected in series with the CH-FJ-2017 structural protein gene VP0, VP3, VP1, respectively, and form three-stage fusion gene sequence THS-VP0, THS-VP3. And THS-VP1.
[0095] (3) Synthesis the three-segment optimized fusion gene fragment by China Great Gene Biotechnology Co., Ltd., and cloned the above-mentioned fragment by molecular cloning technique to the sam...
Embodiment 2
[0108] Example 2 Preparation of a type A seneca virus protein
[0109] 1. Soluble expression of the Sena virus dominant protein
[0110] (1) Remove the expression of the plasmid pGTF transformant and recombinant expression plasmid PET-SVA-VP031 of the expression molecular partner, 10 hwanni-resistant 50 ml of LB liquid medium, 250 rpm, 37 ° C, and culture for about 12 hours. After entering 1L LB liquid medium, 37 ° C culture, etc. OD 600 After the value reached 0.6-0.8, IPTG was added at a final concentration of 0.5 mm, and protein expression was induced at 16 ° C.
[0111] In this example, the fusion of small ubiquitin-like renaissance protein (Sumo) tags of Sumo, SDS-PAGE identification results Figure 8 As shown, where m is a molecular weight Marker; 1 is a precipitate after inducing pre-cleavage; 2 is supernatant after inducing pre-cleavage; 3 is a precipitate after induction of whole bacterial cleavage; 4 is induced after a cleavage After the supernatant, the sample was 5 μl; ...
Embodiment 3
[0126] Example 3 A type of Seneca unit vaccine immunization animal neutralizing antibody response
[0127] Example 2 was prepared by the vaccine in Example 2, the vaccine was prepared after the vaccine was immunized, and the blood was added to 0, 7, 14, 21, 28 days, respectively, and separated serum in progress. And antibody titer detection. Test results Figure 12 As shown, Negative Control is an animal serum of immunized PBS; VLPS Vaccine is an animal serum immunized by the A-type seneca virus protein sub-unit vaccine of the present invention. The results show that the A-type seneca virus-based protein composition RE / SVA / CH-FJ-2017 constructed in animal protein gene VP0, VP3 and VP1 according to the present invention can be immunized after animal immunization Produce a high level of neutralizing antibody, improve the in vivo stability and protection effectiveness of the A-type mouth-and-mouth hypertrophic engineering vaccine.
PUM
Property | Measurement | Unit |
---|---|---|
Radius | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com